Apollomics Inc. Class A Ordinary Shares (APLM)

Apollomics Inc. Class A Ordinary Shares (APLM) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $67.8M; returns 1 day -0.7%, 1 week +3.5%, 1 year -22.6%.

Apollomics Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutic antibodies and drug candidates primarily for oncology and, to a lesser extent, autoimmune diseases. The company leverages proprietary antibody discovery platforms and expertise in protein engineering to advance its pipeline.

Groups APLM belongs to

• Healthcare
• Biotechnology
• Clinical Stage Biotech
• Oncology
• Biopharmaceutical
• Antibody Therapeutics
• Cancer Therapeutics
• Drug Discovery
• China Market
• Hematology

APLM financial model: income statement, cash flow and balance sheet